Search for company

Neimeth International Pharmaceuticals Plc (Nigeria)

Quote Chart
Quote Summary
Last Price 0.9300
Volume 58,651
Turnover 55,718
Market Nigerian Stock Exchange
Market Cap Market Cap 1,459,683
52 Week High 1.59
52 Week Low 0.6400
P/E -6.39
EPS -0.17
Dividend Yield 0.12 (March 31, 2008)
Bookvalue 2,558,012
Enterprise Value 2,263,905
Quote updated on November 27, 2015
Note: data in NGN Thousands.
Select Items to chart them. 2015 Q3C
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 2,606,545
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Company Description

Neimeth International Pharmaceuticals plc is involved in the manufacturing and sales of pharmaceuticals, chemicals and animal health products .The Company had operated in Nigeria for 40 years, producing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms. During the 40 year period (1957-1997), the company established the first pharmaceutical manufacturing plant in Nigeria at Aba, which was…

Contact Information

Legal Address
1, Henry Carr Street,Ikeja Industrial Estate
Ikeja; Lagos; Map
Tel: +234-08158422346,+234-08159491935
Fax: +234-01-4963866

Full name: Neimeth International Pharmaceuticals Plc

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Incorporation Date: 1957

Basic Information
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
2014: Exports Thousands
Export connections ('000)

Ghana (17709000 NGN)
Key Executives
Ownership Details
Inlerceed Health Products Ltd
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Nigeria

Register Your Interest

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.